Research and Markets: Optic Neuritis Pipeline Insights Report 2015
January 28 2015 - 1:15PM
Business Wire
Research and Markets
(http://www.researchandmarkets.com/research/9tcnnj/optic) has
announced the addition of the "Optic Neuritis-Pipeline Insights,
2015" subscription to their offering.
This Optic Neuritis Pipeline Insights report provides
comprehensive insights about pipeline drugs across this indication.
A key objective of the report is to establish the understanding for
all the pipeline drugs that fall under Optic Neuritis.
This report provides information on the therapeutic development
based on the Optic Neuritis dealing with all the pipeline drugs,
comparative analysis at various stages covering Filed, Phase III,
Phase II, Phase I, IND filed, Preclinical, Discovery and unknown
stages, therapeutics assessment by monotherapy and combination
products and molecule type drug information.
The report also covers the companies information involved in the
therapeutic development of the products. It also has highlighted
the discontinued and dormant products.
Key Topics Covered:
- Optic Neuritis Overview
- Optic Neuritis Pipeline Therapeutics
- Optic Neuritis Therapeutics under Development by Companies
- Optic Neuritis Late Stage Products (Filed and Phase III)
- Comparative Analysis
- Optic Neuritis Mid Clinical Stage Products (Phase II)
- Comparative Analysis
- Optic Neuritis Early Clinical Stage Products (Phase I and IND
Filed)
- Comparative Analysis
- Optic Neuritis Discovery and Pre-Clinical Stage Products
- Comparative Analysis
- Drug Candidate Profiles
- Optic Neuritis - Therapeutics Assessment
- Assessment by Monotherapy Products
- Assessment by Combination Products
- Assessment by Route of Administration
- Assessment by Molecule Type
- Optic Neuritis - Discontinued Products
- Optic Neuritis - Dormant Products
- Companies Involved in Therapeutics Development for Optic
Neuritis
- Appendix
For more information visit
http://www.researchandmarkets.com/research/9tcnnj/optic
Research and MarketsLaura Wood, Senior
Managerpress@researchandmarkets.comFor E.S.T Office Hours Call
1-917-300-0470For U.S./CAN Toll Free Call 1-800-526-8630For GMT
Office Hours Call +353-1-416-8900U.S. Fax: 646-607-1907Fax (outside
U.S.): +353-1-481-1716Sector: Pharmaceuticals